Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma is advancing Lucid-MS, a first-in-class drug candidate that directly protects the myelin sheath in multiple sclerosis, toward Phase ...